Finance

Lists
SCPI:IDX
Organon Pharma Indonesia Tbk PT
-100.00%
(-29,000.00) 1D
Sep 14, 4:40:00 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for SCPI...
Volume
0.00
P/E ratio
0.00
EPS
IDR 92,183
Shares outstanding
3.60M
No. of employees
181
Volume
0.00
P/E ratio
0.00
EPS
IDR 92,183
Shares outstanding
3.60M
No. of employees
181
About Organon Pharma Indonesia Tbk PT
CEO-
Employees181
Founded1972
Headquarters-
Sector-
Previous reportsAll values in IDR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.17T
1.21T
863.81B
780.98B
Cost of goods sold
1.02T
1.13T
748.84B
664.42B
Cost of revenue
1.02T
1.13T
748.84B
664.42B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.16B
19.67B
12.86B
14.28B
Operating expense
17.16B
19.67B
12.86B
14.28B
Total operating expenses
1.04T
1.15T
761.70B
678.70B
Operating income
133.81B
69.52B
102.10B
102.28B
Other non operating income
6.27B
3.04B
2.32B
2.13B
EBT including unusual items
138.56B
72.73B
105.52B
108.06B
EBT excluding unusual items
138.56B
72.73B
105.52B
108.06B
Income tax expense
32.27B
20.01B
19.27B
21.46B
Effective tax rate
23.29%
27.51%
18.27%
19.86%
Other operating expenses
-
-
-
-
Net income
106.29B
52.72B
86.24B
86.60B
Net profit margin
9.05%
4.34%
9.98%
11.09%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
66.78M
Interest expense
-3.86M
-191.86M
-66.78M
-
Net interest expenses
-3.86M
-191.86M
-66.78M
66.78M
Depreciation and amortization charges
-
-
-
-
EBITDA
142.79B
78.87B
110.25B
110.43B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps